Effect of Bilateral Maxillary Block on Intraoperative Remifentanil Consumption

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAtatürk Chest Diseases and Chest Surgery Training and Research Hospital

About this trial

The maxillary nerve block is a regional anesthetic technique targeting the sensory distribution of the maxillary nerve and is particularly preferred to provide analgesia in midfacial and maxillary surgical procedures. It has been used to optimize perioperative and postoperative pain control, reduce intraoperative opioid requirements, and support hemodynamic stability in procedures including septorhinoplasty, nasal bone osteotomies, nasal valve surgery, and endoscopic sinus surgery. This study aimed to compare the effects of the timing of bilateral maxillary nerve block administration (post-intubation vs. pre-extubation) on intraoperative remifentanil consumption and postoperative analgesia in patients undergoing septorhinoplasty.

Eligibility criteria

Qualifiers

18 to 65 years old

American Society of Anesthesiologists (ASA) physical status I-II

Body mass index 18 to 30 kg/m2

Septorhinoplasty surgery

Disqualifiers

Patient refusing the procedure

Patients who have previously undergone nasal surgery

Chronic opioid or analgesic use

Patients with allergies to local anesthetics

Trial design

Treatments tested in this trial

  • Preoperative Maxillary Block
  • Postoperative Maxillary Block

Treatment groups

80 Participants
are divided into 2 treatment groups

Sponsors and collaborators